What is Nova-Tech?
Established in 1988 and based in the U.S., Nova-Tech Animal Health is a dedicated provider of sterile manufacturing solutions exclusively for the animal health sector. The company distinguishes itself through its ability to offer customized, flexible, and scalable manufacturing services, built upon decades of industry experience. Nova-Tech's commitment to high-quality production and its nationwide shipping capabilities ensure that it effectively serves the diverse needs of its animal health clientele, positioning it as a key player in its niche market.
How much funding has Nova-Tech raised?
Nova-Tech has raised a total of $888K across 2 funding rounds:
Debt
$350K
Debt
$538K
Debt (2020): $350K with participation from PPP
Debt (2021): $538K led by PPP
Key Investors in Nova-Tech
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Nova-Tech?
The recent major strategic investment signals a pivotal moment for Nova-Tech, likely indicating a transition towards scaling its manufacturing capabilities and potentially expanding its service offerings. This capital injection, alongside the substantial total funding, suggests the company is well-positioned to enhance its market share and explore new avenues for growth within the animal health industry. Future developments may include technological advancements in sterile manufacturing processes or strategic partnerships to broaden its reach and impact.
See full Nova-Tech company page